5,6-MDO-DiPT

Last updated
5,6-MDO-DiPT
5,6-MDO-DiPT.svg
Clinical data
Other names5,6-Methylenedioxy-N,N-diisopropyltryptamine
Routes of
administration 		Unknown [1]
ATC code
  • None
Pharmacokinetic data
Onset of action Unknown [1]
Duration of action Unknown [1]
Identifiers
  • N-[2-(5H-[1,3]dioxolo[4,5-f]indol-7-yl)ethyl]-N-propan-2-ylpropan-2-amine
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C17H24N2O2
Molar mass 288.391 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC1=CNC2=CC3=C(C=C21)OCO3)C(C)C
  • InChI=1S/C17H24N2O2/c1-11(2)19(12(3)4)6-5-13-9-18-15-8-17-16(7-14(13)15)20-10-21-17/h7-9,11-12,18H,5-6,10H2,1-4H3
  • Key:MAICYUOZXYUWMJ-UHFFFAOYSA-N

5,6-MDO-DiPT, also known as 5,6-methylenedioxy-N,N-diisopropyltryptamine, is a lesser-known chemical compound of the tryptamine family. [1] It is the 5,6-methylenedioxy derivative of diisopropyltryptamine (DiPT) and is a analogue of 5-MeO-DiPT. [1] The drug is included as an entry in Alexander Shulgin's 1991 book TiHKAL (Tryptamines I Have Known and Loved). [1] However, Shulgin did not test 5,6-MDO-DiPT and its dose, duration, and effects are unknown. [1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MDO-DiPT. [1] The drug was first described in the scientific literature by Toni B. Kline and colleagues in 1982. [2]

Contents

See also

References

  1. 1 2 3 4 5 6 7 8 Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN   0-9630096-9-9. OCLC   38503252.
  2. ↑ Kline TB, Benington F, Morin RD, Beaton JM (August 1982). "Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety". J Med Chem. 25 (8): 908–913. doi:10.1021/jm00350a005. PMID   7120280.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.